Stanford Health Care, Investigational Drug Service — Stanford, California

Stanford Health Care, Investigational Drug Service is a clinical research site located in Stanford, California, United States 94305.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford Health Care, Investigational Drug Service has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, Breast Neoplasms.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Health Care, Investigational Drug Service?

Stanford Health Care, Investigational Drug Service has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Health Care, Investigational Drug Service conducted?

Stanford Health Care, Investigational Drug Service has 2 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Breast Neoplasms.

Is Stanford Health Care, Investigational Drug Service accredited by Crixeo Health?

Stanford Health Care, Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Health Care, Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.